Clinical trials
Every registered trial of Thymosin Beta-4
12 studies, 2 still enrolling.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Very little human research on Thymosin Beta-4 has been registered.
- 12 registered studies in total.
- 2 are still enrolling people, so this is active research, not just history.
What kind of research
- 12 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 2,004 people took part in those.
How far along it is
- 5 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 1 has published results in the medical literature that anyone can read.
- The research spans 6 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 12 of 12 trials for Thymosin Beta-4.
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
Hudson Biotech
Atherosclerotic Cardiovascular Diseases · Endothelial Dysfunction
RGN-NK-302
Regentree LLC
Neurotrophic Keratopathy
SEER-3
Regentree LLC
Neurotrophic Keratopathy
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
ReGenTree, LLC
Neurotrophic Keratopathy
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
ReGenTree, LLC
Dry Eye Syndromes · Dry Eye
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
ReGenTree, LLC
Dry Eye Syndrome
Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
ReGenTree, LLC
Neurotrophic Keratopathy
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
ReGenTree, LLC
Dry Eye Syndrome
Slow-release Tb4 Collagen and Chitosan Porous Sponge Scaffolds Skin Substitute Treatment is Difficult to Heal Wounds
Chinese PLA General Hospital
Wounds
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
ReGenTree, LLC
Dry Eye Syndrome · Dry Eye
Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
Michigan Cornea Consultants, PC
Dry Eye · Sjogren's Syndrome · Graft vs. Host Disease
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds
ReGenTree, LLC
Diabetes
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Thymosin Beta-4 is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.